Cargando…

Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol

BACKGROUND: Policy is a powerful tool for systematically altering healthcare access and quality, but the research to policy gap impedes translating evidence-based practices into public policy and limits widespread improvements in service and population health outcomes. The US opioid epidemic disprop...

Descripción completa

Detalles Bibliográficos
Autores principales: Crable, Erika L., Grogan, Colleen M., Purtle, Jonathan, Roesch, Scott C., Aarons, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936679/
https://www.ncbi.nlm.nih.gov/pubmed/36797794
http://dx.doi.org/10.1186/s43058-023-00396-5
_version_ 1784890279980957696
author Crable, Erika L.
Grogan, Colleen M.
Purtle, Jonathan
Roesch, Scott C.
Aarons, Gregory A.
author_facet Crable, Erika L.
Grogan, Colleen M.
Purtle, Jonathan
Roesch, Scott C.
Aarons, Gregory A.
author_sort Crable, Erika L.
collection PubMed
description BACKGROUND: Policy is a powerful tool for systematically altering healthcare access and quality, but the research to policy gap impedes translating evidence-based practices into public policy and limits widespread improvements in service and population health outcomes. The US opioid epidemic disproportionately impacts Medicaid members who rely on publicly funded benefits to access evidence-based treatment including medications for opioid use disorder (MOUD). A myriad of misaligned policies and evidence-use behaviors by policymakers across federal agencies, state Medicaid agencies, and managed care organizations limit coverage of and access to MOUD for Medicaid members. Dissemination strategies that improve policymakers’ use of current evidence are critical to improving MOUD benefits and reducing health disparities. However, no research describes key determinants of Medicaid policymakers’ evidence use behaviors or preferences, and few studies have examined data-driven approaches to developing dissemination strategies to enhance evidence-informed policymaking. This study aims to identify determinants and intermediaries that influence policymakers’ evidence use behaviors, then develop and test data-driven tailored dissemination strategies that promote MOUD coverage in benefit arrays. METHODS: Guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework, we will conduct a national survey of state Medicaid agency and managed care organization policymakers to identify determinants and intermediaries that influence how they seek, receive, and use research in their decision-making processes. We will use latent class methods to empirically identify subgroups of agencies with distinct evidence use behaviors. A 10-step dissemination strategy development and specification process will be used to tailor strategies to significant predictors identified for each latent class. Tailored dissemination strategies will be deployed to each class of policymakers and assessed for their acceptability, appropriateness, and feasibility for delivering evidence about MOUD benefit design. DISCUSSION: This study will illuminate key determinants and intermediaries that influence policymakers’ evidence use behaviors when designing benefits for MOUD. This study will produce a critically needed set of data-driven, tailored policy dissemination strategies. Study results will inform a subsequent multi-site trial measuring the effectiveness of tailored dissemination strategies on MOUD benefit design and implementation. Lessons from dissemination strategy development will inform future research about policymakers’ evidence use preferences and offer a replicable process for tailoring dissemination strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-023-00396-5.
format Online
Article
Text
id pubmed-9936679
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99366792023-02-18 Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol Crable, Erika L. Grogan, Colleen M. Purtle, Jonathan Roesch, Scott C. Aarons, Gregory A. Implement Sci Commun Study Protocol BACKGROUND: Policy is a powerful tool for systematically altering healthcare access and quality, but the research to policy gap impedes translating evidence-based practices into public policy and limits widespread improvements in service and population health outcomes. The US opioid epidemic disproportionately impacts Medicaid members who rely on publicly funded benefits to access evidence-based treatment including medications for opioid use disorder (MOUD). A myriad of misaligned policies and evidence-use behaviors by policymakers across federal agencies, state Medicaid agencies, and managed care organizations limit coverage of and access to MOUD for Medicaid members. Dissemination strategies that improve policymakers’ use of current evidence are critical to improving MOUD benefits and reducing health disparities. However, no research describes key determinants of Medicaid policymakers’ evidence use behaviors or preferences, and few studies have examined data-driven approaches to developing dissemination strategies to enhance evidence-informed policymaking. This study aims to identify determinants and intermediaries that influence policymakers’ evidence use behaviors, then develop and test data-driven tailored dissemination strategies that promote MOUD coverage in benefit arrays. METHODS: Guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework, we will conduct a national survey of state Medicaid agency and managed care organization policymakers to identify determinants and intermediaries that influence how they seek, receive, and use research in their decision-making processes. We will use latent class methods to empirically identify subgroups of agencies with distinct evidence use behaviors. A 10-step dissemination strategy development and specification process will be used to tailor strategies to significant predictors identified for each latent class. Tailored dissemination strategies will be deployed to each class of policymakers and assessed for their acceptability, appropriateness, and feasibility for delivering evidence about MOUD benefit design. DISCUSSION: This study will illuminate key determinants and intermediaries that influence policymakers’ evidence use behaviors when designing benefits for MOUD. This study will produce a critically needed set of data-driven, tailored policy dissemination strategies. Study results will inform a subsequent multi-site trial measuring the effectiveness of tailored dissemination strategies on MOUD benefit design and implementation. Lessons from dissemination strategy development will inform future research about policymakers’ evidence use preferences and offer a replicable process for tailoring dissemination strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-023-00396-5. BioMed Central 2023-02-16 /pmc/articles/PMC9936679/ /pubmed/36797794 http://dx.doi.org/10.1186/s43058-023-00396-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Crable, Erika L.
Grogan, Colleen M.
Purtle, Jonathan
Roesch, Scott C.
Aarons, Gregory A.
Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
title Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
title_full Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
title_fullStr Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
title_full_unstemmed Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
title_short Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
title_sort tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936679/
https://www.ncbi.nlm.nih.gov/pubmed/36797794
http://dx.doi.org/10.1186/s43058-023-00396-5
work_keys_str_mv AT crableerikal tailoringdisseminationstrategiestoincreaseevidenceinformedpolicymakingforopioidusedisordertreatmentstudyprotocol
AT grogancolleenm tailoringdisseminationstrategiestoincreaseevidenceinformedpolicymakingforopioidusedisordertreatmentstudyprotocol
AT purtlejonathan tailoringdisseminationstrategiestoincreaseevidenceinformedpolicymakingforopioidusedisordertreatmentstudyprotocol
AT roeschscottc tailoringdisseminationstrategiestoincreaseevidenceinformedpolicymakingforopioidusedisordertreatmentstudyprotocol
AT aaronsgregorya tailoringdisseminationstrategiestoincreaseevidenceinformedpolicymakingforopioidusedisordertreatmentstudyprotocol